ProSci SARS-CoV-2 (COVID-19) Spike L452R Peptide (Delta Variant)

Catalog No.	Quantity
16-595-535	0.05 mg

Catalog No. 16-595-535 Supplier ProSci Supplier No. 9463P0050

Description

Used for Blocking Activity

SARS-CoV-2 (COVID-19) Spike L452R Peptide (Delta Variant)is used for blocking the activity of theSARS-CoV-2 (COVID-19) Spike L452R Antibody (Delta Variant)

SARS-CoV-2 delta variant, a variant of concern (VOC), known as B.1.617.2, was detected in India in October of 2020. However, it rapidly spread all over of the world and now it is the dominant variant in the world, which account for more than 99% of the cases. This variant carries at least 13 mutations in spike protein across the sub lineages, including L452R, D614G, P681R and K417N, which can increase the affinity to the human ACE2 receptor. Enhanced transmission of the Delta variant was observed globally, which is at least 2.5 times more contagious as the other variants. The Delta variant affects the effectiveness of COVID19 vaccine and is resistant to neutralization to some extent.

Specifications

• Gene ID (Entrez): 43740568
• Species: SARS-CoV-2
• Accession Number: QHD43416
• Common Name: surface glycoprotein
• Concentration: 200 μg/mL
• Content And Storage: Store SARS-CoV-2 (COVID-19) Spike L452R Peptide (Delta Variant) at -20°C, stable for one year.
• Format: Liquid
• Formulation: PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin and 0.02% sodium azide
• For Use With (Application): Blocking Assay
• Gene Symbol: S
• Quantity: 0.05 mg
• Sequence: 9 amino acids near the receptor binding domain of SARS-CoV-2 (COVID-19) Spike L452R (Delta Variant).
• Synonym: SARS-CoV-2 Spike 156-157 EF antibody: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Surface Glycoprotein, Spike protein